（投资中国）赢创大中华区总裁夏赋良：中国起点，全球输出

Core Viewpoint - The president of Evonik Greater China, Xia Fuliang, emphasizes that China serves as a starting point for global output of local R&D achievements, marking a strategic shift from "local application for China" to "innovation output from China for the world" [1][3]. Group 1: Strategic Developments - Evonik will debut in the new materials section at the upcoming China International Import Expo, showcasing 11 innovative products, including 4 global debuts and 2 locally developed products [1][3]. - The company plans to establish the Yulin Evonik Integration Innovation Center in Shaanxi and collaborate with partners to launch new products during the expo [3][4]. Group 2: R&D and Innovation - In 2024, Evonik will upgrade its Shanghai R&D center to the "Evonik Shanghai Innovation Park," which will become one of its six global core R&D bases, featuring advanced facilities and 35 laboratories [4]. - The Shanghai Innovation Park aims to enhance resource allocation and technical advantages across various business sectors, with plans to double the number of R&D personnel by 2027 [4][5]. Group 3: Market Confidence and Financial Outlook - Evonik projects a sales revenue of €15.2 billion (approximately ¥125.65 billion) for China in 2024, with an EBITDA of €2.1 billion (approximately ¥17.36 billion) [6]. - The company recognizes China as the largest chemical production country, accounting for 42% of the global market share in 2024, and views it as a core growth engine for the global chemical industry [6].